Trial intelligence / Profile preview

Artequin in children with acute uncomplicated P. falciparum malaria

NCT00243737Phase 2Completed

Sponsor
Albert Schweitzer Hospital
Start
Oct 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of artesunate + mefloquine in Plasmodium falciparum malaria, sponsored by Albert Schweitzer Hospital. Started Oct 2005; status: completed.

02

Drugs

artesunate + mefloquine
03

Conditions

Plasmodium falciparum malaria

Beyond the preview

Go deeper on NCT00243737.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00243737.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call